BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17149664)

  • 1. [On the 2007 edition of case definitions for the surveillance of notifiable infectious diseases in Germany].
    Poggensee G; Benzler J; Eckmanns T; Krause G;
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Dec; 49(12):1189-94. PubMed ID: 17149664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [On the 2004 edition of case definitions for the surveillance of notifiable infectious diseases in Germany].
    Benzler J; Krause G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Feb; 47(2):141-6. PubMed ID: 15205812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The 2015 edition of case definitions for the surveillance of notifiable infectious diseases in Germany].
    Diercke M; Benzler J; Schöneberg I; Mücke I; Altmann D; Claus H; Gilsdorf A;
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Sep; 57(9):1107-10. PubMed ID: 25096238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complementary to notification required by the national Protection against Infection Act. State-specific mandatory infectious disease notification in Saxony-Anhalt].
    Oppermann H; Thriene B; Zaumseil S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Sep; 48(9):990-7. PubMed ID: 16160886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Infectious disease surveillance based on the Protection against Infection Act in the German public health sector].
    Dreesman J; Benzler J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Sep; 48(9):979-89. PubMed ID: 16160885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [First evaluation of the surveillance systems of notifiable diseases under the infectious disease control law in Germany].
    Krause G; Altmann D; Claus H; Hellenbrand W; Buchholz U; Hamouda O; Breuer T; Ammon A; Kramer M; ;
    Gesundheitswesen; 2003 Mar; 65 Suppl 1():S8-12. PubMed ID: 12649788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revised surveillance case definitions.
    Commun Dis Intell Q Rep; 2013 Jun; 37(2):E189-92. PubMed ID: 24340782
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mandatory notification of infectious diseases and agents in Germany: development and suggestions for improvement].
    Heudorf U; Gottschalk R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Jun; 63(6):777-789. PubMed ID: 32399605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case definitions for diseases under national surveillance.
    Can Commun Dis Rep; 2000 May; 26 Suppl 3():i-iv 1-122. PubMed ID: 11055080
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experiences of the German public health service with the implementation of a new infections disease control act--results of focus group discussions].
    Krause G
    Gesundheitswesen; 2004; 66(8-9):522-7. PubMed ID: 15372354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rare infectious diseases in Germany. Obligatory notification results].
    Schöneberg I
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 May; 51(5):539-46. PubMed ID: 18696144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nosocomial Legionnaires' disease--results from the analysis of Germany's surveillance data; 2004-2006].
    Stöcker P; Brodhun B; Buchholz U
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Feb; 52(2):219-27. PubMed ID: 19214458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SurvNet@RKI--a multistate electronic reporting system for communicable diseases.
    Faensen D; Claus H; Benzler J; Ammon A; Pfoch T; Breuer T; Krause G
    Euro Surveill; 2006; 11(4):100-3. PubMed ID: 16645245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The National Reference Centres and Reference Laboratories. Importance and tasks].
    Laude G; Ammon A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Sep; 48(9):998-1004. PubMed ID: 16160887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced surveillance of infectious diseases : the 2006 FIFA World Cup experience, Germany.
    Schenkel K; Williams C; Eckmanns T; Poggensee G; Benzler J; Josephsen J; Krause G
    Euro Surveill; 2006; 11(12):234-8. PubMed ID: 17370965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future directions for notifiable diseases: tuberculosis-related laws in the Philippines.
    Lee Y
    Global Health; 2018 Aug; 14(1):87. PubMed ID: 30134993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Syphilis on the march. New reporting requirements].
    Hamouda O; Marcus U
    Hautarzt; 2005 Feb; 56(2):124-32. PubMed ID: 15662533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Under-reporting of notifiable infectious disease hospitalizations in a health board region in Ireland: room for improvement?
    Brabazon ED; O'Farrell A; Murray CA; Carton MW; Finnegan P
    Epidemiol Infect; 2008 Feb; 136(2):241-7. PubMed ID: 17394674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Communicable Diseases Surveillance (4th quarter, 2012).
    Commun Dis Intell Q Rep; 2012 Dec; 36(4):E361-8. PubMed ID: 23646383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research results on sensitivity of surveillance on the infectious diseases of PSSE Zwoleń].
    Kacperczyk-Baran T
    Przegl Epidemiol; 2006; 60(2):205-11. PubMed ID: 16964671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.